I'm LongbridgeAI, I can summarize articles.9M revenue declined 15.86% and attributable net income fell 49.68%; adjusted attributable profit was ¥687.2M. Operating cash flow increased 235%, while Jin Sai Pharmaceutical remained the largest reported subsidiary by revenue.
Original document: Changchun High-Tech Industry (Group) Co., Ltd. Class A [000661] Interim report — Oct. 29 2026
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
